HK1205696A1 - Compositions for topical treatment of microbial infections - Google Patents

Compositions for topical treatment of microbial infections

Info

Publication number
HK1205696A1
HK1205696A1 HK15106385.3A HK15106385A HK1205696A1 HK 1205696 A1 HK1205696 A1 HK 1205696A1 HK 15106385 A HK15106385 A HK 15106385A HK 1205696 A1 HK1205696 A1 HK 1205696A1
Authority
HK
Hong Kong
Prior art keywords
compositions
topical treatment
microbial infections
infections
microbial
Prior art date
Application number
HK15106385.3A
Other languages
English (en)
Chinese (zh)
Inventor
Patrick Schlievert
Original Assignee
Hennepin Life Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hennepin Life Sciences filed Critical Hennepin Life Sciences
Publication of HK1205696A1 publication Critical patent/HK1205696A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK15106385.3A 2012-04-20 2015-07-06 Compositions for topical treatment of microbial infections HK1205696A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261636203P 2012-04-20 2012-04-20
US201261650755P 2012-05-23 2012-05-23
PCT/US2013/037430 WO2013159029A1 (en) 2012-04-20 2013-04-19 Compositions for topical treatment of microbial infections

Publications (1)

Publication Number Publication Date
HK1205696A1 true HK1205696A1 (en) 2015-12-24

Family

ID=49380685

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15106385.3A HK1205696A1 (en) 2012-04-20 2015-07-06 Compositions for topical treatment of microbial infections

Country Status (14)

Country Link
US (3) US9724295B2 (xx)
EP (2) EP2838524B1 (xx)
JP (1) JP6353437B2 (xx)
KR (1) KR20150008086A (xx)
CN (1) CN104363904A (xx)
AU (1) AU2013249086A1 (xx)
BR (1) BR112014026058A2 (xx)
CA (1) CA2870674C (xx)
ES (1) ES2958621T3 (xx)
HK (1) HK1205696A1 (xx)
IL (1) IL235130A0 (xx)
IN (1) IN2014DN08810A (xx)
MX (1) MX2014012676A (xx)
WO (1) WO2013159029A1 (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050215634A1 (en) * 2003-11-11 2005-09-29 Schlievert Patrick M Regulation of cell membrane-mediated effects
CA2870674C (en) * 2012-04-20 2022-05-03 Hennepin Life Sciences Compositions for topical treatment of microbial infections
WO2015120310A1 (en) * 2014-02-07 2015-08-13 University Of Iowa Research Foundation Method for decolonization of staphylococcus aureus
CA2968824C (en) 2014-10-16 2023-10-17 Natureza, Inc. Formulations having anti-inflammatory activity and antimicrobial activity against gram-positive bacteria
US20180228758A1 (en) * 2015-08-19 2018-08-16 Hennepin Life Sciences, Llc Compositions and methods to treat infected ear conditions
US20180289656A1 (en) * 2015-10-14 2018-10-11 Hennepin Life Sciences, Llc Compositions and methods to treat urinary tract infections
AU2017296016A1 (en) * 2016-07-11 2019-01-24 Hennepin Life Sciences, Llc Compositions for sexually transmitted diseases
CN109200063A (zh) * 2017-06-29 2019-01-15 中山大学 脆弱拟杆菌在制备用于治疗和预防结核病的药物中的应用
WO2019033125A1 (en) * 2017-08-11 2019-02-14 Natureza, Inc. LAURIC ACID DERIVATIVES HAVING INHIBITORY ACTIVITY AGAINST GRAM POSITIVE AND / OR NEGATIVE GRAM ORGANISMS
WO2019079150A1 (en) * 2017-10-18 2019-04-25 Hennepin Life Sciences, Llc COMPOSITIONS AND METHODS FOR TREATING ATOPIC DERMATITIS
WO2020112847A2 (en) * 2018-11-30 2020-06-04 Locus Ip Company, Llc Immune supplement composition
FR3093650B1 (fr) 2019-03-11 2022-12-30 Id4Feed Nouveau solvant d’extraction, de solubilisation et/ou de formulation de composés volatiles et non-volatiles d’intérêt en alimentation et santé animale, procédé de préparation et utilisations associées
GB201906653D0 (en) * 2019-05-10 2019-06-26 Cc Biotech Ltd Polypeptides for treatment of bacterial infections
CN111759852A (zh) * 2020-08-04 2020-10-13 驯鹿(北京)管理咨询有限公司 一种阴道用药物组合物及其药物制剂、制备方法和用途
WO2022046668A1 (en) * 2020-08-22 2022-03-03 Luc Montagnier Compositions and methods for reducing the transmissivity of illnesses
US11572342B2 (en) 2020-09-18 2023-02-07 Niche Biopharmaceuticals LLC Antimicrobial and antiviral sulfur containing glycerol monoester derivatives
EP4351729A1 (en) * 2021-05-26 2024-04-17 Hennepin Life Sciences, LLC Composition for topical treatment of microbial infections

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208257A (en) * 1986-04-21 1993-05-04 Kabara Jon J Topical antimicrobial pharmaceutical compositions and methods
CA1302280C (en) * 1986-04-21 1992-06-02 Jon Joseph Kabara Topical antimicrobial pharmaceutical compositions and methods
US4746515A (en) * 1987-02-26 1988-05-24 Alza Corporation Skin permeation enhancer compositions using glycerol monolaurate
US5256405A (en) * 1991-12-30 1993-10-26 Tom's Of Maine Herbal deodorant
US5260053A (en) * 1991-12-30 1993-11-09 Tom's Of Maine Herbal deodorant
JPH10500686A (ja) * 1994-05-20 1998-01-20 ノババックス インコーポレイテッド 抗菌性水中油エマルジョン
US5569461A (en) 1995-02-07 1996-10-29 Minnesota Mining And Manufacturing Company Topical antimicrobial composition and method
US5906814A (en) * 1995-12-07 1999-05-25 The Andrew Jergens Company Topical film-forming compositions
US6645506B1 (en) * 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
US20020031556A1 (en) * 2000-07-21 2002-03-14 Lindahl Ake R. Stabilized hydrogen peroxide composition and method of making a stabilized hydrogen peroxide composition
US20050058673A1 (en) * 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
US20050215634A1 (en) 2003-11-11 2005-09-29 Schlievert Patrick M Regulation of cell membrane-mediated effects
US8796332B2 (en) 2004-08-03 2014-08-05 Regents Of The University Of Minnesota Compositions and methods for controlling infections
JP2008512447A (ja) * 2004-09-13 2008-04-24 ブハラット セルムズ アンド ヴァクシンズ リミテッド 防腐作用を有する静脈投与用の安定な乳剤組成物
ATE420625T1 (de) * 2005-08-05 2009-01-15 Bharat Serums & Vaccines Ltd Intravenöse propofol-emulsionszusammensetzungen mit konservierendem effekt
MY140578A (en) * 2005-12-07 2009-12-31 Malaysian Agricultural Res And Dev Inst Mardi Modified coconut oils with broad antimicrobial spectrum
WO2010059800A1 (en) * 2008-11-21 2010-05-27 Mcneil-Ppc, Inc. Coating compositions and coated substrates for articles of manufacture used in contact with human body surfaces
EP2477619A4 (en) * 2009-09-17 2013-07-03 B Eugene Guthery NASAL, INJURY AND SKIN FORMULATIONS AND METHODS FOR THE CONTROL OF STAPHYLOCOCCIS RESISTANT TO ANTIBIOTICS AND OTHER GRAM-POSITIVE BACTERIA
CA2870674C (en) 2012-04-20 2022-05-03 Hennepin Life Sciences Compositions for topical treatment of microbial infections
US10579108B2 (en) 2016-03-20 2020-03-03 Case Cam LLC Phone case with camera

Also Published As

Publication number Publication date
KR20150008086A (ko) 2015-01-21
US20180092835A1 (en) 2018-04-05
WO2013159029A1 (en) 2013-10-24
EP2838524A1 (en) 2015-02-25
CA2870674A1 (en) 2013-10-24
CN104363904A (zh) 2015-02-18
ES2958621T3 (es) 2024-02-12
AU2013249086A1 (en) 2014-10-30
US20160175244A1 (en) 2016-06-23
JP2015514782A (ja) 2015-05-21
EP4241844A2 (en) 2023-09-13
BR112014026058A2 (pt) 2017-06-27
JP6353437B2 (ja) 2018-07-04
IN2014DN08810A (xx) 2015-05-22
EP2838524A4 (en) 2015-12-30
IL235130A0 (en) 2014-12-31
US11786454B2 (en) 2023-10-17
MX2014012676A (es) 2015-06-22
EP2838524B1 (en) 2023-07-05
CA2870674C (en) 2022-05-03
EP4241844A3 (en) 2023-11-08
US20130281532A1 (en) 2013-10-24
US9724295B2 (en) 2017-08-08

Similar Documents

Publication Publication Date Title
HK1205696A1 (en) Compositions for topical treatment of microbial infections
HK1216389A1 (zh) 治療局部微生物感染的方法
HK1209755A1 (en) Mannose derivatives for treating bacterial infections
HK1203361A1 (en) Topical oil composition for the treatment of fungal infections
PL2696890T3 (pl) Leczenie infekcji drobnoustrojowych
PT2694021E (pt) Composição cicatrizante para aplicação tópica
GB201217097D0 (en) Treatment of bacterial infection
EP2897613A4 (en) TREATMENT COMPOSITIONS
HRP20160150T1 (xx) Lijeäśenje streptokoknih infekcija
IL237035A0 (en) Antibacterial compound for external use
EP2844258A4 (en) METHOD AND COMPOSITIONS FOR TREATING BACTERIAL INFECTIONS
EP2916653A4 (en) ANTIBIOTIC METHODS AND ANTIBIOTIC COMPOSITIONS FOR BACTERIAL INFECTIONS
PL2617412T3 (pl) Kompozycja do leczenia miejscowego
PT2939665T (pt) Composição farmacêutica para tratamento de infecções por hiv
ZA201308116B (en) Avian-based treatment for microbial infections
PT2431030E (pt) Tratamento de infeções fúngicas
EP2529728A4 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF BACTERIAL INFECTIONS
HK1206633A1 (en) Composition for treatment of warts
EP2670407A4 (en) TREATMENT OF BACTERIAL INFECTIONS
EP2685820A4 (en) COMPOSITIONS AND METHODS FOR TREATING INFECTIONS
GB201212715D0 (en) Treatment of fungal infections
GB201204364D0 (en) Topical treatment of wounds